News
President Donald Trump has given major pharmaceutical companies 60 days to slash prescription drug prices or face action.
Last week, President Donald J. Trump sent letters to 17 of the leading pharmaceutical companies outlining steps they must take to lower prescription ...
Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.
In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...
It plans to invest $50 billion in the US over five years, including building its largest-ever manufacturing facility in ...
AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ...
Donald Trump has sacked America’s top statistician after official data showed a sharp slowdown in the US jobs market. The US ...
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
Pharmaceutical stocks across the global markets have taken a hit after Trump demanded drug companies lower prices for ...
France's CAC 40 fell 1.8%, and Germany's DAX dropped 1.7%, underlining the significant impact the new measures are having across Europe's largest economies.
Inflation in the US is rising and likely to rise further, but the American economy is growing regardless - seemingly ...
A fresh ultimatum demanding "binding commitments" to lower U.S. drug prices sent pharma firms scrambling Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results